Related Experiment Videos

Model experiments to evaluate the protective role of thiols and other reductants against oxidative damage

M Tamba¹, G Simone, M Quintiliani

¹Istituto F.R.A.E. (C.N.R.), Via de Castagnoli, Bologna, Italy.

Pharmacology & Therapeutics

|January 1, 1988

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination.

ESMO gastrointestinal oncology·2026

Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis.

ESMO gastrointestinal oncology·2026

Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma.

ESMO gastrointestinal oncology·2026

Prognostic nutritional index as a prognostic marker in metastatic esophageal squamous-cell carcinoma treated with immune checkpoint inhibitor.

ESMO gastrointestinal oncology·2026

Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice.

ESMO gastrointestinal oncology·2026

The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy.

ESMO gastrointestinal oncology·2026

See all related articles